Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Gala vs Gimme Care

Gimme Care costs $19 less a month, and both sell semaglutide and tirzepatide.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Gala logo

Gala

8.7
★★★★☆4.4/5

Best for: moving between compounded and brand without changing seller

Visit Gala →
VS
Gimme Care logo

Gimme Care

8.7
★★★★☆4.4/5

Best for: semaglutide at $130/month, 39% below the typical price

Visit Gimme Care →

If you are choosing between Gala and Gimme Care, the first difference is cost: Gimme Care is $19 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. They tie at 8.7 on our six-part score.

Gala vs Gimme Care price

Gimme Care is the cheaper way in: $130 a month against $149 a month at Gala. That is $19 less each month (13% lower), or about $228 over a year of treatment.

Drug by drug: Semaglutide is cheaper at Gimme Care ($130 a month vs $179 a month); tirzepatide is cheaper at Gala ($149 a month vs $163 a month).

Medications and formats

Both sell semaglutide and tirzepatide.

On format, Gala prices compounded injections and brand-name pens, while Gimme Care prices compounded injections.

If you want the FDA-approved brand rather than a compounded version, Gala is the only one of the two with a brand-name price.

Where each one treats patients

Gala lists 50 states, and Gimme Care lists 51 states.

They overlap in 50 states. Gimme Care alone covers District of Columbia.

Pricing

Gala

Compounded GLP-1 (all doses)Compounded
$179$129/mo
Save 28% right now
semaglutide

$179/mo on a yearly subscription, all doses included. Gala's FAQ says 'starting at just $199 per month (with a 3-month plan).' A promo page offers 'starting at $129/month with $120 off your first shipment' on monthly, 3-, 6- and 12-month plans. Exact plan prices appear only after the intake questionnaire.

Compounded GLP-1/GIP (all doses)Compounded
$179/mo
tirzepatide

$179/month on a yearly subscription, all doses included; the $120-off-first-shipment promo applies. Tirzepatide plan prices are shown only after intake.

Microdosing GLP-1/GIPCompounded
$149/mo
tirzepatide

$149/month, yearly subscription; 'Low-dose GLP-1/GIP for sustained energy, sleep and metabolic balance.'

Ozempic (brand)Brand-name
$1299/mo
semaglutide

'Ozempic® Brand-name semaglutide $1,299/month' — unchanged. Wegovy pill still 'Coming soon / Pricing at launch' (not a priced row).

Gimme Care

Compounded Semaglutide (3-mo)Compounded
$130/mo
semaglutide
Compounded Semaglutide (1-mo)Compounded
$160/mo
semaglutide
Compounded Tirzepatide (3-mo)Compounded
$163/mo
tirzepatide
Compounded Tirzepatide (1-mo)Compounded
$199/mo
tirzepatide

What each price covers

Both prices cover the clinician visit, the medication itself and shipping.

Gala is silent on lab work and coaching.

Gimme Care is silent on lab work and coaching.

Gala

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Gimme Care

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Where each one scores higher

Overall they tie at 8.7 out of 10.

Gala is stronger on value (8.7 vs 8.1).

Gimme Care is stronger on trust & safety (8.5 vs 7.5).

Effectiveness, user experience, accessibility and support are within half a point.

How we score

Gala

8.7/10

Overall

Gimme Care

8.7/10

Value25%

8.7A
vs
B
8.1

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

7.5A
vs
B
8.5

Accessibility10%

10.0A
vs
B
10.0

Support10%

7.0A
vs
B
7.0

FDA warning letters

Neither Gala nor Gimme Care has an FDA warning letter on record with us.

Features & Coverage

FeatureGalaGimme Care
Starting Price$149/mo✓$130/mo
Features✓7 features5 features
States Available50✓51
Compounded✓ Yes✓ Yes
Brand Name✓ Yes—
FSA/HSA Accepted——
FDA Warning LettersNoneNone

About Gala

A yearly subscription is the format: compounded semaglutide and compounded tirzepatide are sold that way, with a cheaper microdosing program beside them and brand-name Ozempic on the same menu. The corporate name is AI Coaching Inc., which does business as Gala GLP-1 and is incorporated in Delaware. Providers licensed in every one of the 50 states, plus shipping at no cost, are what the marketing site claims. A Wegovy pill taken orally is flagged as coming soon.

Read our full Gala review →

About Gimme Care

Gimme Care sells compounded semaglutide at $130-$160/mo and compounded tirzepatide at $163-$199/mo, microdose options included. It is LegitScript verified, available in all 50 states plus DC, with no membership fees.

Read our full Gimme Care review →

Pros & Cons

Gala

What we like

  • Semaglutide costs $179 a month, close to the $184 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $149 a month, 40% below the $250 median for compounded tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price stays the same as your dose goes up
  • The monthly price includes the medication, clinician visits and shipping
  • Serves all 50 states
  • We found no FDA warning letters issued to Gala

Watch-outs

  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Gimme Care

What we like

  • Semaglutide costs $130 a month, 29% below the $184 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $163 a month, 35% below the $250 median for compounded tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price stays the same as your dose goes up
  • The monthly price includes the medication, clinician visits and shipping
  • Serves all 50 states
  • We found no FDA warning letters issued to Gimme Care

Watch-outs

  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: Gala

Gala is where we would start, above all for moving between compounded and brand without changing seller. Gimme Care undercuts it by $19 a month, so if the monthly bill is what decides it, Gimme Care is the pick. Gimme Care fits better if semaglutide at $130/month, 39% below the typical price is your priority.

Choose Gala if…

You want moving between compounded and brand without changing seller and an opening price near $149 a month.

Choose Gimme Care if…

You want semaglutide at $130/month, 39% below the typical price and an opening price near $130 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

9.2

He & She MD

Starting below a standard dose, with microdose tiers

5.9

Wellorithm

Compounded semaglutide at $247/month

6.6

Willow

Seeing what it charges before you answer any medical questions

Gala vs Gimme Care: FAQ

Gimme Care. It starts at $130 a month; Gala starts at $149 a month, $19 more per month.
Yes, both sell semaglutide and tirzepatide.
Gimme Care: 51 states against 50, with 50 in common.
Both include the clinician visit, the medication itself and shipping.
Gala has none. Gimme Care has none.
Gala pays us a commission on sign-ups through our links; Gimme Care does not. Scores are computed the same way for both.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.